MENO'CALM CONFORT +
Food supplement declared in France, decision dated 23 October 2026
MENO'CALM CONFORT + is a food supplement declared in France. Status: declared in France, may be marketed. 2 rules of use apply to its ingredients (limits and warnings).
- Brand
- not provided
- Food business operator placing the product on the market
- SANTAROME SAS
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Tablet
- Daily dose
- 2 comprimés par jour
- Directions for use
- Prendre 1 à 2 comprimés par jour selon l’intensité de l’inconfort, avec un grand verre d’eau.
- Intended populations
- Men and women aged 18 and over, Women
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Breastfeeding women, Allergy to salicylate derivatives, Children (under 12), Young children (aged 1 to 3), Pregnant women, Kidney failure, Infants (under 1 year), Taking anticoagulants, Taking antidepressants, Prolonged use, Children (under 6), Children (under 10)
- Objectives stated by the manufacturer (these are not authorised claims)
- Menopause, Bones, Nervous system
Declaration 375369, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Tanacetum parthenium (L.) Sch.Bip. | Parties aériennes | Extrait sec hydroalcoolique | 31 mg |
| Crocus sativus L. | Stigmates | Extrait sec hydroalcoolique | 30 mg |
| Vaccinium vitis-idaea L. | Jeune pousse | Autre macérât | 5 mg |
| Ribes nigrum L. | Bourgeon | Autre macérât | 5 mg |
| Betula pendula Roth | Bourgeon | Autre macérât | 5 mg |
| Lavandula angustifolia Mill. | Sommités fleuries | Distillation | 1 mg |
Substances
| Name | Per day |
|---|---|
| tryptophane | 50 mg |
| théanine | 17 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Pollen | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Carbonate de calcium | Calcium | 2,500 mg | 800 mg |
| Sels calciques de l'acide orthophosphorique | Calcium | 2,500 mg | 800 mg |
| Acide ptéroylmonoglutamique | Folates (vitamine B9) | 1,000 µg | 200 µg |
| Oxyde de magnésium | Magnésium | 250 mg | 300 mg |
| Cyanocobalamine | Vitamine B12 | pas d'effet indésirable défini | dose annulled by the French Council of State in 2011 |
| Chlorhydrate de pyridoxine | Vitamine B6 | 12 mg | 2 mg |
| Cholécalciférol | Vitamine D | 100 µg (4,000 UI) | 5 µg (200 UI) |
Additives
E422, E414, E570, E464, E460
Other ingredients
Alcool, Eau purifiée
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Réservé à la femme adulte. Déconseillé aux femmes enceintes ou allaitantes ainsi qu’aux personnes sous traitement anticoagulant ou antidépresseur. Déconseillé en cas d’insuffisance cardiaque ou rénale oedémateuses, d’allergie croisée connue, en particulier aux plantes de la famille des Asteraceae ou d’allergie aux dérivés salicylés et d’intolérance aux anti-inflammatoires non stéroïdiens. Déconseillé aux personnes allergiques au pollen, ayant de l’asthme ou un terrain atopique. Ne pas utiliser de manière prolongée (maximum 14 jours). Au-delà, observer une pause avant de renouveler. Prendre l’attache d’un professionnel de santé avant utilisation.
Regulatory points
- Conditions légales
Vaccinium vitis-idaea L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Conditions légales
Betula pendula Roth: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Tanacetum parthenium (L.) Sch.Bip.
Read the warning, when it applies and the studies cited
FEVERFEW - TANACETUM PARTHENIUM
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Biggs et al. 1982).
Sources cited by Health Canada (2)
- Biggs MJ, Johnson ES, Persaud NP, Ratcliffe DM. Platelet aggregation in patients using feverfew for migraine. Lancet 1982;320(8301):776. PubMed
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
Applies to products providing 250 mg or less of dried herb top and/or leaf, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/ physician before use if you are breastfeeding (Boon 2000).
Sources cited by Health Canada (1)
- Boon H. Feverfew. In: Chandler F, editor. Herbs: Everyday Reference for Health Professionals. Ottawa (ON): Canadian Pharmacists Association and the Canadian Medical Association; 2000.
Contraindications
Applies to products providing 250 mg or less of dried herb top and/or leaf, per day.
Do not use if you are pregnant (Gardner and McGuffin 2013; Brinker 2010).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Ration (FL): Taylor and Francis Group; 2013.
Applies to products providing more than 250 mg of dried herb top and/or leaf, per day.
Do not use if you are pregnant or breastfeeding (EMA 2020).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: All products.
Stop use if hypersensitivity/allergy occurs (EMA 2020; Paulsen et al. 2001; Hausen 1996).
Sources cited by Health Canada (2)
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
When using this product you may experience sore mouth, mouth ulcers and/or gastrointestinal discomfort/disturbances (EMA 2020; Gardner and McGuffin 2013; Murphy et al. 1988; Johnson et al. 1985).
Sources cited by Health Canada (3)
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Ration (FL): Taylor and Francis Group; 2013.
- Johnson ES, Kadam NP, Hylands DM, Hylands PJ. 1985. Efficacy of feverfew as prophylactic treatment of migraine. British Medical Journal 291(6495):569-573.
- Murphy JJ, Heptinstall S, Mitchell JR. Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet 1988;332(8604):189-192.
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
- Betula pendula Roth
Read the warning, when it applies and the studies cited
Birch
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney or cardiovascular disorders (Brinker 2010; Bradley 2006; ESCOP 2003; Blumenthal et al. 1998).
Sources cited by Health Canada (4)
- Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Riggins C, Rister R, editors. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin (TX): American Botanical Council; 1998.
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Brinker 2010).
Sources cited by Health Canada (1)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- théanine
Read the warning, when it applies and the studies cited
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.